— Know what they know.
Not Investment Advice
Also trades as: CRY (NYSE) · $vol 4M

AORT NYSE

Artivion, Inc.
1W: -0.8% 1M: -38.6% 3M: -40.6% YTD: -48.8% 1Y: -22.0% 3Y: +54.5% 5Y: -21.5%
$22.46
-0.31 (-1.36%)
After Hours: $22.40 (-0.06, -0.27%)
Weekly Expected Move ±15.2%
$16 $19 $23 $26 $30
NYSE · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 32 · $1.1B mcap · 46M float · 1.22% daily turnover · Short 71% of daily vol

Cash Flow Trends

Operating Cash Flow
$38M +71.5% ▲
5Y CAGR: +25.3%
Capital Expenditures
$39M -249.0% ▼
5Y CAGR: +39.7%
Free Cash Flow
-$911K -108.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$11M +309.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$15M-$19M-$31M-$13M$10M
Depreciation & Amort.$24M$22M$23M$24M$22M
Stock-Based Comp.$11M$12M$14M$14M$24M
Change in Working Capital-$33M-$26M-$16M-$17M-$22M
Other Non-Cash Items$15M$7M$30M$16M$4M
Operating Cash Flow-$3M-$5M$19M$22M$38M
— Investing Activities —
Capital Expenditures-$13M-$11M-$7M-$11M-$39M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$19M$0$0$0$0
Other Investing-$249K$0$7M-$17M-$3M
Investing Cash Flow$6M-$11M-$502K-$28M-$42M
— Financing Activities —
Net Debt Issuance-$3M-$3M-$3M-$358K-$2M
Stock Repurchased-$2M-$2M-$559K$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$7M$3M$4M-$3M$2M
Financing Cash Flow-$12M-$2M$865K$2M$13M
Net Change in Cash-$7M-$16M$20M-$5M$11M
Cash End of Period$55M$39M$59M$53M$65M
Free Cash Flow-$16M-$16M$11M$11M-$911K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms